INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$172K
610 sh
Jan 23, 2026Jan 26, 2026
Page 1397 of 1786
← PrevNext →
traded Jan 23, 2026
+3d
SEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$60K
214 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

23
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Grant or award
A$41K
423 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

22
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$228K
5,000 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,500 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
MT
Mawakana TekedraDirector
INTUINTUIT INC.
Option exercise
M—
694 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
KJ
Kroll Lara JSVP & Chief Accounting Officer
CHRDChord Energy Corp
Grant or award
A—
634 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,188 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
RN
Robuck Richard NEVP, CFO and Treasurer
CHRDChord Energy Corp
Grant or award
A—
3,461 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
BE
Brown Daniel EDirector, President and CEO
CHRDChord Energy Corp
Grant or award
A—
10.5K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
KB
Kinney Shannon BrowningEVP, CAO, GC & Corp Secretary
CHRDChord Energy Corp
Grant or award
A—
8,642 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,600 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC Form 4

Evidence

21
HJ
Henke Darrin J.EVP and COO
CHRDChord Energy Corp
Grant or award
A—
3,461 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
RR
Roslansky RyanDirector
INTUINTUIT INC.
Option exercise
M—
418 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
4,725 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC Form 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
3,813 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
SJ
Singh Harmit JEVP & Chief Fin. & Growth Ofc.
LLEVILEVI STRAUSS & CO
Grant or award
A—
213.7K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.64M
632.9K sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

21
KB
Kinney Shannon BrowningEVP, CAO, GC & Corp Secretary
CHRDChord Energy Corp
Grant or award
A—
2,700 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
HJ
Henke Darrin J.EVP and COO
CHRDChord Energy Corp
Grant or award
A—
11.1K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$41K
1,116 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
RR
Roslansky RyanDirector
INTUINTUIT INC.
Option exercise
M—
469 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
UM
Urist MarshallEVP, Research & Investments
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$805K
20.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$41K
1,126 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC Form 4

Evidence

21
GC
Gowasack Andrew CarlDirector, President
IDAIT Stamp Inc
Grant or award
A—
68.4K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

20
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$18K
64 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

20
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$39K
138 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$742K
3,487 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$918K
4,330 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
LE
Lee David EricVICE CHAIR, WINTRUST FINANCIAL
WTFCWINTRUST FINANCIAL CORP
Grant or award
A$408K
2,680 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$447K
2,083 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$548K
2,600 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$278K
1,300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

18
HC
Huntsman CaroleChief Commercial Officer
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$167K
340 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

17
GC
Goeltz II Robert C.Chief Financial Officer
RCUSArcus Biosciences, Inc.
Grant or award
A—
24.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
AP
Ahlstrom PaulDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
AK
Ambrose KristenSVP & Chief Accounting Officer
VRTXVERTEX PHARMACEUTICALS INC / MA
Grant or award
A—
2,950 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

17
CD
Crane Benton DelossDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
KB
Kinney Shannon BrowningEVP, CAO, GC & Corp Secretary
CHRDChord Energy Corp
Grant or award
A—
2,160 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

17
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Grant or award
A—
21.1K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence